Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Tag-based next generation sequencing: a feasible and reliable assay for EGFR T790M mutation detection in circulating tumor DNA of non small cell lung cancer patients.

Dono M, De Luca G, Lastraioli S, Anselmi G, Dal Bello MG, Coco S, Vanni I, Grossi F, Vigani A, Genova C, Ferrarini M, Ravetti JL, Zupo S.

Mol Med. 2019 Apr 27;25(1):15. doi: 10.1186/s10020-019-0082-5.

2.

The involvement of microRNA in the pathogenesis of Richter syndrome.

Van Roosbroeck K, Bayraktar R, Calin S, Bloehdorn J, Dragomir MP, Okubo K, Bertilaccio MTS, Zupo S, You MJ, Gaidano G, Rossi D, Chen SS, Chiorazzi N, Thompson PA, Ferrajoli A, Bertoni F, Stilgenbauer S, Keating MJ, Calin GA.

Haematologica. 2019 May;104(5):1004-1015. doi: 10.3324/haematol.2018.203828. Epub 2018 Nov 8.

3.

Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study.

Iannitto E, Bellei M, Amorim S, Ferreri AJM, Marcheselli L, Cesaretti M, Haioun C, Mancuso S, Bouabdallah K, Gressin R, Tripodo C, Traverse-Glehen A, Baseggio L, Zupo S, Stelitano C, Castagnari B, Patti C, Alvarez I, Liberati AM, Merli M, Gini G, Cabras MG, Dupuis J, Tessoulin B, Perrot A, Re F, Palombi F, Gulino A, Zucca E, Federico M, Thieblemont C.

Br J Haematol. 2018 Dec;183(5):755-765. doi: 10.1111/bjh.15641. Epub 2018 Nov 8.

PMID:
30407629
4.

MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways.

Malpeli G, Barbi S, Tosadori G, Greco C, Zupo S, Pedron S, Brunelli M, Bertolaso A, Scupoli MT, Krampera M, Kamga PT, Croce CM, Calin GA, Scarpa A, Zamò A.

Oncotarget. 2018 Jul 3;9(51):29753-29771. doi: 10.18632/oncotarget.25707. eCollection 2018 Jul 3.

5.

MicroRNA signatures and Foxp3+ cell count correlate with relapse occurrence in follicular lymphoma.

Malpeli G, Barbi S, Greco C, Zupo S, Bertolaso A, Scupoli MT, Krampera M, Kamga PT, Croce CM, Scarpa A, Zamò A.

Oncotarget. 2018 Apr 13;9(28):19961-19979. doi: 10.18632/oncotarget.24987. eCollection 2018 Apr 13.

6.

Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolence.

Cutrona G, Tripodo C, Matis S, Recchia AG, Massucco C, Fabbi M, Colombo M, Emionite L, Sangaletti S, Gulino A, Reverberi D, Massara R, Boccardo S, de Totero D, Salvi S, Cilli M, Pellicanò M, Manzoni M, Fabris S, Airoldi I, Valdora F, Ferrini S, Gentile M, Vigna E, Bossio S, De Stefano L, Palummo A, Iaquinta G, Cardillo M, Zupo S, Cerruti G, Ibatici A, Neri A, Fais F, Ferrarini M, Morabito F.

Sci Transl Med. 2018 Feb 14;10(428). pii: eaal1571. doi: 10.1126/scitranslmed.aal1571.

PMID:
29444977
7.

Retrospective cytological evaluation of indeterminate thyroid nodules according to the British Thyroid Association 2014 classification and comparison of clinical evaluation and outcomes.

Giusti M, Massa B, Balestra M, Calamaro P, Gay S, Schiaffino S, Turtulici G, Zupo S, Monti E, Ansaldo G.

J Zhejiang Univ Sci B. 2017 Jul;18(7):555-566. doi: 10.1631/jzus.B1600075.

8.

Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53.

Malpeli G, Barbi S, Zupo S, Tosadori G, Scardoni G, Bertolaso A, Sartoris S, Ugel S, Vicentini C, Fassan M, Adamo A, Krampera M, Scupoli MT, Croce CM, Scarpa A.

Oncotarget. 2017 Feb 14;8(7):11809-11826. doi: 10.18632/oncotarget.14683.

9.

Heterogeneous expression of the collagen receptor DDR1 in chronic lymphocytic leukaemia and correlation with progression.

Barisione G, Fabbi M, Cutrona G, De Cecco L, Zupo S, Leitinger B, Gentile M, Manzoni M, Neri A, Morabito F, Ferrarini M, Ferrini S.

Blood Cancer J. 2017 Jan 6;6(1):e513. doi: 10.1038/bcj.2016.121. No abstract available.

10.

Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy.

Cutrona G, Matis S, Colombo M, Massucco C, Baio G, Valdora F, Emionite L, Fabris S, Recchia AG, Gentile M, Neumaier CE, Reverberi D, Massara R, Boccardo S, Basso L, Salvi S, Rosa F, Cilli M, Zupo S, Truini M, Tassone P, Calabrese M, Negrini M, Neri A, Morabito F, Fais F, Ferrarini M.

Leukemia. 2017 Sep;31(9):1894-1904. doi: 10.1038/leu.2016.394. Epub 2017 Jan 5.

PMID:
28053325
11.

Small cell lung cancer transformation and the T790M mutation: A case report of two acquired mechanisms of TKI resistance detected in a tumor rebiopsy and plasma sample of EGFR-mutant lung adenocarcinoma.

Alì G, Bruno R, Giordano M, Prediletto I, Marconi L, Zupo S, Fedeli F, Ribechini A, Chella A, Fontanini G.

Oncol Lett. 2016 Nov;12(5):4009-4012. Epub 2016 Sep 26.

12.

Cytokines can counteract the inhibitory effect of MEK-i on NK-cell function.

Manzini C, Venè R, Cossu I, Gualco M, Zupo S, Dono M, Spagnolo F, Queirolo P, Moretta L, Mingari MC, Pietra G.

Oncotarget. 2016 Sep 20;7(38):60858-60871. doi: 10.18632/oncotarget.11504.

13.

BRAF Mutations in an Italian Regional Population: Implications for the Therapy of Thyroid Cancer.

Monti E, Bovero M, Mortara L, Pera G, Zupo S, Gugiatti E, Dono M, Massa B, Ansaldo GL, Massimo G.

Int J Endocrinol. 2015;2015:138734. doi: 10.1155/2015/138734. Epub 2015 Nov 26.

14.

A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients.

Gentile M, Shanafelt TD, Cutrona G, Molica S, Tripepi G, Alvarez I, Mauro FR, Di Renzo N, Di Raimondo F, Vincelli I, Todoerti K, Matis S, Musolino C, Fabris S, Vigna E, Levato L, Zupo S, Angrilli F, Consoli U, Festini G, Longo G, Cortelezzi A, Arcari A, Federico M, Mannina D, Recchia AG, Neri A, Kay NE, Ferrarini M, Morabito F.

Leukemia. 2016 Jun;30(6):1440-3. doi: 10.1038/leu.2015.333. Epub 2015 Dec 9. No abstract available.

PMID:
26648537
15.

Interleukin 21 Controls mRNA and MicroRNA Expression in CD40-Activated Chronic Lymphocytic Leukemia Cells.

De Cecco L, Capaia M, Zupo S, Cutrona G, Matis S, Brizzolara A, Orengo AM, Croce M, Marchesi E, Ferrarini M, Canevari S, Ferrini S.

PLoS One. 2015 Aug 25;10(8):e0134706. doi: 10.1371/journal.pone.0134706. eCollection 2015.

16.

Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study.

Gentile M, Cutrona G, Molica S, Ilariucci F, Mauro FR, Di Renzo N, Di Raimondo F, Vincelli I, Todoerti K, Matis S, Musolino C, Fabris S, Lionetti M, Levato L, Zupo S, Angrilli F, Consoli U, Festini G, Longo G, Cortelezzi A, Musto P, Federico M, Neri A, Ferrarini M, Morabito F.

Eur J Haematol. 2016 Jan;96(1):36-45. doi: 10.1111/ejh.12545. Epub 2015 Mar 31.

PMID:
25753656
17.

Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs.

Londin E, Loher P, Telonis AG, Quann K, Clark P, Jing Y, Hatzimichael E, Kirino Y, Honda S, Lally M, Ramratnam B, Comstock CE, Knudsen KE, Gomella L, Spaeth GL, Hark L, Katz LJ, Witkiewicz A, Rostami A, Jimenez SA, Hollingsworth MA, Yeh JJ, Shaw CA, McKenzie SE, Bray P, Nelson PT, Zupo S, Van Roosbroeck K, Keating MJ, Calin GA, Yeo C, Jimbo M, Cozzitorto J, Brody JR, Delgrosso K, Mattick JS, Fortina P, Rigoutsos I.

Proc Natl Acad Sci U S A. 2015 Mar 10;112(10):E1106-15. doi: 10.1073/pnas.1420955112. Epub 2015 Feb 23.

18.

Report from the OECI Oncology Days 2014.

van Harten W, Stanta G, Bussolati G, Riegman P, Hoefler G, Becker K, Folprecht G, Truini M, Haybaeck J, Buiga R, Dono M, Bagg A, López Guerrero J, Zupo S, Lemare F, de Lorenzo F, Goedbloed N, Razavi D, Lövey J, Cadariu P, Rollandi G, Paparo F, Pierotti M, Ciuleanu T, De Paoli P, Weiner G, Saghatchian M, Lombardo C.

Ecancermedicalscience. 2014 Dec 31;8:496. doi: 10.3332/ecancer.2014.496. eCollection 2014.

19.

Papillary thyroid cancer in a struma ovarii: a report of a rare case.

Monti E, Mortara L, Zupo S, Dono M, Minuto F, Truini M, Naseri M, Giusti M.

Hormones (Athens). 2015 Jan-Mar;14(1):154-9. doi: 10.14310/horm.2002.1518.

20.

The interleukin (IL)-31/IL-31R axis contributes to tumor growth in human follicular lymphoma.

Ferretti E, Tripodo C, Pagnan G, Guarnotta C, Marimpietri D, Corrias MV, Ribatti D, Zupo S, Fraternali-Orcioni G, Ravetti JL, Pistoia V, Corcione A.

Leukemia. 2015 Apr;29(4):958-67. doi: 10.1038/leu.2014.291. Epub 2014 Oct 6.

PMID:
25283844
21.

Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study.

Gentile M, Cutrona G, Mosca L, Matis S, Fabris S, Lionetti M, Ilariucci F, Zupo S, Musolino C, Levato L, Molica S, Di Raimondo F, Vincelli I, Di Rienzo N, Pesce EA, Angrilli F, Federico M, Neri A, Ferrarini M, Morabito F.

Am J Hematol. 2014 Jul;89(7):743-50. doi: 10.1002/ajh.23729. Epub 2014 Apr 18.

22.

NAC, tiron and trolox impair survival of cell cultures containing glioblastoma tumorigenic initiating cells by inhibition of cell cycle progression.

Monticone M, Taherian R, Stigliani S, Carra E, Monteghirfo S, Longo L, Daga A, Dono M, Zupo S, Giaretti W, Castagnola P.

PLoS One. 2014 Feb 28;9(2):e90085. doi: 10.1371/journal.pone.0090085. eCollection 2014.

23.

Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages.

Giannoni P, Pietra G, Travaini G, Quarto R, Shyti G, Benelli R, Ottaggio L, Mingari MC, Zupo S, Cutrona G, Pierri I, Balleari E, Pattarozzi A, Calvaruso M, Tripodo C, Ferrarini M, de Totero D.

Haematologica. 2014 Jun;99(6):1078-87. doi: 10.3324/haematol.2013.091405. Epub 2014 Feb 21.

24.

Central nervous system involvement in mycosis fungoides: relevance of tcr gene testing in cerebrospinal fluid.

Giorli E, Traverso E, Benedetti L, Zupo S, Del Sette B, Cerruti G, Godani M.

Springerplus. 2014 Jan 17;3:29. doi: 10.1186/2193-1801-3-29. eCollection 2014.

25.

Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma.

Dono M, Angelini G, Cecconi M, Amaro A, Esposito AI, Mirisola V, Maric I, Lanza F, Nasciuti F, Viaggi S, Gualco M, Bandelloni R, Truini M, Coviello DA, Zupo S, Mosci C, Pfeffer U.

Br J Cancer. 2014 Feb 18;110(4):1058-65. doi: 10.1038/bjc.2013.804. Epub 2014 Jan 14.

26.

Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study.

Gentile M, Cutrona G, Fabris S, Pesce EA, Baldini L, Di Raimondo F, Musolino C, Di Tonno P, Di Renzo N, Molica S, Brugiatelli M, Ilariucci F, Zupo S, Matis S, Maura F, Vigna E, Angrilli F, Recchia AG, Quarta G, Iannitto E, Fragasso A, Musto P, Spriano M, Vincelli I, Vallisa D, Cortelezzi A, Mauro FR, Foà R, Federico M, Neri A, Ferrarini M, Morabito F.

Am J Hematol. 2013 Jul;88(7):539-44. doi: 10.1002/ajh.23448. Epub 2013 Jun 12.

27.

Low percentage of KRAS mutations revealed by locked nucleic acid polymerase chain reaction: implications for treatment of metastatic colorectal cancer.

Dono M, Massucco C, Chiara S, Sonaglio C, Mora M, Truini A, Cerruti G, Zoppoli G, Ballestrero A, Truini M, Ferrarini M, Zupo S.

Mol Med. 2013 Feb 8;18:1519-26. doi: 10.2119/molmed.2012.00175.

28.

Seasonal and pandemic (A/H1N1 2009) MF-59-adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens.

Bedognetti D, Ansaldi F, Zanardi E, Durando P, Sertoli MR, Massucco C, Balleari E, Racchi O, Zoppoli G, Orsi A, Alicino C, Icardi G, Marincola FM, Zupo S, Ferrarini M, De Maria A.

Blood. 2012 Aug 30;120(9):1954-7. No abstract available.

29.

Incidental finding of peripheral B-cell non-Hodgkin lymphoma, lymphocytic/CLL type, of the gallbladder in a patient with chronic cholecystitis.

Imenpour H, Castagnola M, De Silva G, Zupo S, Truini M, Merlo E, Anselmi L.

Pathologica. 2011 Oct;103(5):307-10.

PMID:
22393688
30.

Multiorgan infiltration by CD8+ T cells and 1p;16p translocation in a patient with hypogammaglobulinemia and a reduced number of B cells.

Vultaggio A, Matucci A, D'Elios MM, Andreucci E, Giglio S, Annunziato F, Zupo S, Maggi E.

Int Arch Allergy Immunol. 2012;158(2):206-10. doi: 10.1159/000331117. Epub 2012 Jan 26.

PMID:
22286841
31.

Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo.

Cocco C, Di Carlo E, Zupo S, Canale S, Zorzoli A, Ribatti D, Morandi F, Ognio E, Airoldi I.

Leukemia. 2012 Jun;26(6):1365-74. doi: 10.1038/leu.2011.363. Epub 2011 Dec 23.

PMID:
22193967
32.

Apoptotic activity of the marine diatom Cocconeis scutellum and eicosapentaenoic acid in BT20 cells.

Nappo M, Berkov S, Massucco C, Di Maria V, Bastida J, Codina C, Avila C, Messina P, Zupo V, Zupo S.

Pharm Biol. 2012 Apr;50(4):529-35. doi: 10.3109/13880209.2011.611811. Epub 2011 Dec 2.

PMID:
22136301
33.

A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment.

Ferretti E, Bertolotto M, Deaglio S, Tripodo C, Ribatti D, Audrito V, Blengio F, Matis S, Zupo S, Rossi D, Ottonello L, Gaidano G, Malavasi F, Pistoia V, Corcione A.

Leukemia. 2011 Aug;25(8):1268-77. doi: 10.1038/leu.2011.88. Epub 2011 May 6.

PMID:
21546901
34.

Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens.

Bedognetti D, Zoppoli G, Massucco C, Zanardi E, Zupo S, Bruzzone A, Sertoli MR, Balleari E, Racchi O, Messina M, Caltabiano G, Icardi G, Durando P, Marincola FM, Boccardo F, Ferrarini M, Ansaldi F, De Maria A.

J Immunol. 2011 May 15;186(10):6044-55. doi: 10.4049/jimmunol.1004095. Epub 2011 Apr 15.

35.

More on the determination of Ki-67 as a novel potential prognostic marker in B-cell chronic lymphocytic leukemia.

Morabito F, Cutrona G, Gentile M, Loiacono F, Matis S, Recchia AG, Gigliotti V, Callea V, Zupo S, Ferrarini M.

Leuk Res. 2010 Dec;34(12):e326-8. doi: 10.1016/j.leukres.2010.07.036. Epub 2010 Aug 17. No abstract available.

PMID:
20723976
36.

Heterogeneous expression and function of IL-21R and susceptibility to IL-21-mediated apoptosis in follicular lymphoma cells.

de Totero D, Capaia M, Fabbi M, Croce M, Meazza R, Cutrona G, Zupo S, Loiacono F, Truini M, Ferrarini M, Ferrini S.

Exp Hematol. 2010 May;38(5):373-83. doi: 10.1016/j.exphem.2010.02.008. Epub 2010 Mar 1.

PMID:
20193734
37.

Prognostic relevance of in vitro response to cell stimulation via surface IgD in binet stage a CLL.

Morabito F, Cutrona G, Gentile M, Fabbi M, Matis S, Colombo M, Reverberi D, Megna M, Spriano M, Callea V, Vigna E, Rossi E, Lucia E, Festini G, Zupo S, Molica S, Neri A, Ferrarini M.

Br J Haematol. 2010 Apr;149(1):160-3. doi: 10.1111/j.1365-2141.2009.08032.x. Epub 2009 Dec 8. No abstract available.

PMID:
19995391
38.

Follicular mucinosis: a clinicopathologic, histochemical, immunohistochemical and molecular study comparing the primary benign form and the mycosis fungoides-associated follicular mucinosis.

Rongioletti F, De Lucchi S, Meyes D, Mora M, Rebora A, Zupo S, Cerruti G, Patterson JW.

J Cutan Pathol. 2010 Jan;37(1):15-9. doi: 10.1111/j.1600-0560.2009.01338.x. Epub 2009 Jul 13.

PMID:
19615011
39.

Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia.

Morabito F, Cutrona G, Gentile M, Matis S, Todoerti K, Colombo M, Sonaglio C, Fabris S, Reverberi D, Megna M, Spriano M, Lucia E, Rossi E, Callea V, Mazzone C, Festini G, Zupo S, Molica S, Neri A, Ferrarini M.

Br J Haematol. 2009 Jun;146(1):44-53. doi: 10.1111/j.1365-2141.2009.07703.x. Epub 2009 May 6.

PMID:
19438486
40.

LPS induces KH-type splicing regulatory protein-dependent processing of microRNA-155 precursors in macrophages.

Ruggiero T, Trabucchi M, De Santa F, Zupo S, Harfe BD, McManus MT, Rosenfeld MG, Briata P, Gherzi R.

FASEB J. 2009 Sep;23(9):2898-908. doi: 10.1096/fj.09-131342. Epub 2009 May 7.

PMID:
19423639
41.

Progesterone receptor B recruits a repressor complex to a half-PRE site of the estrogen receptor alpha gene promoter.

De Amicis F, Zupo S, Panno ML, Malivindi R, Giordano F, Barone I, Mauro L, Fuqua SA, Andò S.

Mol Endocrinol. 2009 Apr;23(4):454-65. doi: 10.1210/me.2008-0267. Epub 2009 Jan 15.

42.

Leptin and leptin receptor in pig spermatozoa: evidence of their involvement in sperm capacitation and survival.

Aquila S, Rago V, Guido C, Casaburi I, Zupo S, Carpino A.

Reproduction. 2008 Jul;136(1):23-32. doi: 10.1530/REP-07-0304. Epub 2008 Mar 26.

PMID:
18367502
43.

Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells.

Cutrona G, Colombo M, Matis S, Fabbi M, Spriano M, Callea V, Vigna E, Gentile M, Zupo S, Chiorazzi N, Morabito F, Ferrarini M.

Haematologica. 2008 Mar;93(3):413-22. doi: 10.3324/haematol.11646. Epub 2008 Feb 20.

44.

Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation.

Piccaluga PP, Agostinelli C, Califano A, Carbone A, Fantoni L, Ferrari S, Gazzola A, Gloghini A, Righi S, Rossi M, Tagliafico E, Zinzani PL, Zupo S, Baccarani M, Pileri SA.

Cancer Res. 2007 Nov 15;67(22):10703-10.

45.

Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas.

Calin GA, Liu CG, Ferracin M, Hyslop T, Spizzo R, Sevignani C, Fabbri M, Cimmino A, Lee EJ, Wojcik SE, Shimizu M, Tili E, Rossi S, Taccioli C, Pichiorri F, Liu X, Zupo S, Herlea V, Gramantieri L, Lanza G, Alder H, Rassenti L, Volinia S, Schmittgen TD, Kipps TJ, Negrini M, Croce CM.

Cancer Cell. 2007 Sep;12(3):215-29.

46.

Human sperm express a functional androgen receptor: effects on PI3K/AKT pathway.

Aquila S, Middea E, Catalano S, Marsico S, Lanzino M, Casaburi I, Barone I, Bruno R, Zupo S, Andò S.

Hum Reprod. 2007 Oct;22(10):2594-605. Epub 2007 Jul 26.

PMID:
17656415
47.

Donor lymphocyte infusions for the treatment of minimal residual disease in acute leukemia.

Dominietto A, Pozzi S, Miglino M, Albarracin F, Piaggio G, Bertolotti F, Grasso R, Zupo S, Raiola AM, Gobbi M, Frassoni F, Bacigalupo A.

Blood. 2007 Jun 1;109(11):5063-4. No abstract available.

48.

Complementation of the oxidatively damaged DNA repair defect in Cockayne syndrome A and B cells by Escherichia coli formamidopyrimidine DNA glycosylase.

Ropolo M, Degan P, Foresta M, D'Errico M, Lasigliè D, Dogliotti E, Casartelli G, Zupo S, Poggi A, Frosina G.

Free Radic Biol Med. 2007 Jun 15;42(12):1807-17. Epub 2007 Mar 12.

PMID:
17512460
49.

Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets.

Piccaluga PP, Agostinelli C, Califano A, Rossi M, Basso K, Zupo S, Went P, Klein U, Zinzani PL, Baccarani M, Dalla Favera R, Pileri SA.

J Clin Invest. 2007 Mar;117(3):823-34. Epub 2007 Feb 15.

50.

Highly homologous T-cell receptor beta sequences support a common target for autoreactive T cells in most patients with paroxysmal nocturnal hemoglobinuria.

Gargiulo L, Lastraioli S, Cerruti G, Serra M, Loiacono F, Zupo S, Luzzatto L, Notaro R.

Blood. 2007 Jun 1;109(11):5036-42. Epub 2007 Feb 6.

Supplemental Content

Support Center